Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 24
Phase 41

Trial Status

Completed9
Terminated4

Role Distribution

Principal Investigator13
PI Rate100%

Activity Timeline

Clinical Trials (13)

NCT06595576Not ApplicableCompleted
Cannabis Edibles and Simulated Driving
CannabisDriving Under the Influence
PrincipalinvestigatorStart date: 2024-10-01
NCT04801641Phase 2Terminated
A Pilot Trial of Nabilone for the Treatment of Obesity
Obesity
PrincipalinvestigatorStart date: 2021-09-17
NCT03037060Not ApplicableCompleted
Exploring Regulation and Function of Dopamine D3 Receptors in Alcohol Use Disorders: A [11C]-(+)-PHNO Study
Alcohol Use Disorder
PrincipalinvestigatorStart date: 2016-12-01
NCT01999530Phase 1Completed
The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot Study
Healthy
PrincipalinvestigatorStart date: 2013-11-01
NCT00390923Not ApplicableTerminated
Testing a Full Substitution Therapy Approach As Treatment of Tobacco Dependence
Nicotine Dependence
Principalinvestigator
NCT01228994Phase 2Terminated
Baclofen for Smoking Cessation in a Non-Psychiatric Population
Nicotine Dependence
Principalinvestigator
NCT01632189Not ApplicableCompleted
The Effect of Varenicline on D2/D3 Receptor Binding in Smokers
Nicotine Dependence
Principalinvestigator
NCT01638377Phase 4Terminated
Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers
Alcohol Dependence
Principalinvestigator
NCT01747850Phase 2Completed
Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence
Cannabis Dependence
Principalinvestigator

Showing 10 of 13 trials

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Bruna Brands, PhD

Centre for Addiction and Mental Health

Related
4 trials

Shared therapeutic areas:

Psychomotor Impairment

Worked with same sponsors:

Centre for Addiction and Mental HealthOntario Ministry of Transportation
Collaborated on 1 trial
Similarity Score14%

Robert Mann, PhD

Centre for Addiction and Mental Health

Related
1 trials

Shared therapeutic areas:

Psychomotor Impairment

Worked with same sponsors:

Centre for Addiction and Mental HealthOntario Ministry of Transportation
Collaborated on 1 trial
Similarity Score14%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

HealthyCannabisObesity
Similarity Score9%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

HealthyAlcohol Use DisorderAlcoholism
Similarity Score9%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

ObesityHeavy Drinking
Similarity Score6%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

ObesityHealthy
Similarity Score6%

Elliot Stein, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
20 trials

Shared therapeutic areas:

Nicotine DependenceCannabis Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score6%

Mikhail Samsonov

R-Pharm

Related
34 trials

Shared therapeutic areas:

HealthyAlcoholism
Similarity Score6%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Healthy
Similarity Score3%

Waqar ahmed awan, Phd

Riphah International University

Related
20 trials

Shared therapeutic areas:

Healthy
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (13)

Showing 13 of 13 trials

NCT06595576Not ApplicablePrincipalInvestigator

Cannabis Edibles and Simulated Driving

CannabisDriving Under the Influence
Completed
NCT04801641Phase 2PrincipalInvestigator

A Pilot Trial of Nabilone for the Treatment of Obesity

Obesity
Terminated
NCT03037060Not ApplicablePrincipalInvestigator

Exploring Regulation and Function of Dopamine D3 Receptors in Alcohol Use Disorders: A [11C]-(+)-PHNO Study

Alcohol Use Disorder
Completed
NCT01999530Phase 1PrincipalInvestigator

The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot Study

Healthy
Completed
NCT00390923Not ApplicablePrincipalInvestigator

Testing a Full Substitution Therapy Approach As Treatment of Tobacco Dependence

Nicotine Dependence
Terminated
NCT01228994Phase 2PrincipalInvestigator

Baclofen for Smoking Cessation in a Non-Psychiatric Population

Nicotine Dependence
Terminated
NCT01632189Not ApplicablePrincipalInvestigator

The Effect of Varenicline on D2/D3 Receptor Binding in Smokers

Nicotine Dependence
Completed
NCT01638364Phase 1PrincipalInvestigator

Dopamine Release in the Human Brain Following Alcohol Administration

Heavy Drinking
Completed
NCT01638377Phase 4PrincipalInvestigator

Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers

Alcohol Dependence
Terminated
NCT01747850Phase 2PrincipalInvestigator

Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence

Cannabis Dependence
Completed
NCT01876810Phase 2PrincipalInvestigator

Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction

Nicotine Dependence
Completed
NCT02514720Not ApplicablePrincipalInvestigator

Nicotine Metabolizers and [11C]-(+)-PHNO

Nicotine Dependence
Completed
NCT02710578Not ApplicablePrincipalInvestigator

Alcohol Effects on Driving-related Skills of Young Drivers

Psychomotor Impairment
Completed

All 13 trials loaded